Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010

Obstetrics and Gynecology

Volumn 120, Issue 5, 2012, Pages 1105-1115

  Rogo Gupta, Lisa ^a,b   Rodriguez, Larissa V ^a,b   Litwin, Mark S ^a,b   Herzog, Thomas J ^a,b   Neugut, Alfred I ^a,b   Lu, Yu Shiang ^a,b   Raz, Shlomo ^a,b   Hershman, Dawn L ^a,b   Wright, Jason D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DEVICE SAFETY; FEMALE; GYNECOLOGIST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; ICD-9; MAJOR CLINICAL STUDY; PELVIC ORGAN PROLAPSE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE DIFFERENCE; SURGEON; SURGICAL MESH; TREND STUDY; URINE INCONTINENCE; UROLOGIST;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; PELVIC ORGAN PROLAPSE; SURGICAL MESH; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 84868143911     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31826ebcc2     Document Type: Article

References (36)

1. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008;300:1311-6.
2. Chong EC, Khan AA, Anger JT. The financial burden of stress urinary incontinence among women in the United States. Curr Urol Rep 2011;12:358-62.
3. Economic impact of urologic disease. In: Litwin MS, Saigal CS, editors. Urologic Diseases in America 2012. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012. p. 463-96.
4. Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. The Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD003882. DOI: 10.1002/14651858.CD003882.pub4.
5. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-6.
6. Menchen LC, Wein AJ, Smith AL. An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh. Curr Urol Rep 2012, March 22 [epub ahead of print].
7. Vaginal placement of synthetic mesh for pelvic organ prolapse. Committee Opinion No. 513. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;118:5.
8. Maher C, Feiner B, Baessler K, Adams EJ, Hagen S, Glazener CM. Surgical management of pelvic organ prolapse in women. The Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD004014. DOI: 10.1002/14651858. CD004014.pub4.
9. Maher C, Baessler K, Glazener CM, Adams EJ, Hagen S. Surgical management of pelvic organ prolapse in women. The Cochrane Database of Systematic 2004, Issue 4. Art. No.: CD004014. DOI: 10.1002/14651858.CD004014.pub2.
10. Pelvic organ prolapse. Practice Bulletin No. 85. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007; 110:717-29.
11. Murphy M, Society of Gynecologic Surgeons Systematic Review Group. Clinical practice guidelines on vaginal graft use from the society of gynecologic surgeons. Obstet Gynecol 2008;112:1123-30.
12. U.S. Food and Drug Administration. Public Health Notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. March 9, 2018. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PublicHealthNotifications. Retrieved April 23, 2012.
13. U.S. Food and Drug Administration. Surgical placement of mesh to repair pelvic organ prolapse poses risks. July 13, 2011. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements. Retrieved April 24, 2012.
14. Premier Research Services. Available at: https://www.premierinc. com/quality-safety/tools-services/prs/index.jsp. Retrieved April 24, 2012.
15. Auerbach AD, Hilton JF, Maselli J, Pekow PS, Rothberg MB, Lindenauer PK. Case volume, quality of care, and care efficiency in coronary artery bypass surgery. Arch Intern Med 2010;170:1202-8.
16. Bozic KJ, Maselli J, Pekow PS, Lindenauer PK, Vail TP, Auerbach AD. The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery. J Bone Joint Surg Am 2010;92:2643-52.
17. Lagu T, Rothberg MB, Nathanson BH, Pekow PS, Steingrub JS, Lindenauer PK. The relationship between hospital spending and mortality in patients with sepsis. Arch Intern Med 2011;171:292-9.
18. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010; 303:2359-67.
19. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2010;303:2035-42.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
22. Rogers WB, Erickson DR. Early adoption of new devices: flying on untested wings. J Urol 2012;187:783-4.
23. Ostergard DR. Evidence-based medicine for polypropylene mesh use compared with native tissue vaginal prolapse repair. Urology 2012;79:12-4.
24. Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon's specialty for outcome after colorectal cancer surgery. The Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD005391. DOI: 10.1002/14651858. CD005391.pub3.
25. Rogo-Gupta LJ, Lewin SN, Kim JH, Burke WM, Sun X, Herzog TJ, et al. The effect of surgeon volume on outcomes and resource use for vaginal hysterectomy. Obstet Gynecol 2010;116:1341-7.
26. Wallenstein MR, Ananth CV, Kim JH, Burke WM, Hershman DL, Lewin SN, et al. Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol 2012;119:709-16.
27. Anger JT, Litwin MS, Wang Q , Pashos CL, Rodriguez LV. The effect of concomitant prolapse repair on sling outcomes. J Urol 2008;180:1003-6.
28. Jonsson Funk M, Levin PJ, Wu JM. Trends in the surgical management of stress urinary incontinence. Obstet Gynecol 2012;119:845-51.
29. Tseng TY, Cancel QV, Fesperman SF, Kuebler HR, Sun L, Robertson CN, et al. The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy. J Urol 2007;177:1318-23.
30. Flanigan RC, Badlani G, Howards S, Dmochowski R, Winters JC, Santucci RA, et al. White paper on genitourinary reconstructive medicine: where do we stand and what should the future look like? Linthicum (MD): American Urologic Association; 2011.
31. Curfman GD, Redberg RF. Medical devices-balancing regulation and innovation. N Engl J Med 2011;365:975-7.
32. Challoner DR, Vodra WW. Medical devices and health-creating a new regulatory framework for moderate-risk devices. N Engl J Med 2011;365:977-9.
33. Walker EP. FDA's fast-track medical device approval process under fire. April 14, 2011. Available at: http://abcnews. go.com/Health/Wellness/medical- devices-government-officeaccountability-finds-holes-fdas/story?id513368464. Retrieved April 24, 2012.
34. O'Connor AB. Building comparative efficacy and tolerability into the FDA approval process. JAMA 2010;303:979-80.
35. FDA to discuss risks and benefits of metal-on-metal hip replacements. March 29, 2012. Available at: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements. Retrieved April 24, 2012.
36. Urogynecologic surgical mesh implants. 2012 January 4, 2012. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ ImplantsandProsthetics/UroGynSurgicalMesh/default.htm. Retrieved April 24, 2012.